Andrew Dakos adds 16,000 Total Return Securities Fund (SWZ) shares

Rhea-AI Filing Summary

Total Return Securities Fund President and CEO Andrew Dakos, who is also a director of SWZ, reported open-market purchases of a total of 16,000 shares of common stock on February 3–4, 2026, at prices between $5.96 and $6.04 per share.

Following these transactions, Dakos directly owned 39,453 shares of SWZ common stock. An additional 2,003 shares are held by a limited partnership in which he has a beneficial interest, and he disclaims beneficial ownership beyond any pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dakos Andrew

(Last) (First) (Middle)

250 PEHLE AVE.

SUITE 708

(Street)

SADDLE BROOK NJ 07663

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Total Return Securities Fund [ SWZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								2,003	I	Limited Partnership(1)
Common Stock	02/03/2026		P		7,000	A	$5.97	30,453	D
Common Stock	02/03/2026		P		3,000	A	$5.96	33,453	D
Common Stock	02/04/2026		P		2,000	A	$6.04	35,453	D
Common Stock	02/04/2026		P		2,000	A	$6.03	37,453	D
Common Stock	02/04/2026		P		2,000	A	$6.02	39,453	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares are held by a limited partnership in which Mr. Dakos has a beneficial interest. Mr. Dakos disclaims beneficial interest in such shares except to the extent of any pecuniary interest therein.

	/s/ Stephanie Darling, Power of Attorney for Andrew Dakos	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Andrew Dakos report for SWZ?

Andrew Dakos reported buying a total of 16,000 SWZ common shares in open-market purchases on February 3–4, 2026. The shares were acquired at prices between $5.96 and $6.04 per share, increasing his direct ownership stake.

At what prices did Andrew Dakos buy SWZ shares in February 2026?

Andrew Dakos bought SWZ common stock at prices ranging from $5.96 to $6.04 per share. These purchases occurred on February 3 and 4, 2026, as reported in his Form 4 filed under Section 16.

How many SWZ shares does Andrew Dakos own after the reported trades?

After the reported trades, Andrew Dakos directly owns 39,453 SWZ common shares. The Form 4 also shows 2,003 additional shares held indirectly by a limited partnership in which he has a beneficial interest, subject to his stated beneficial ownership disclaimer.

What indirect SWZ holdings related to Andrew Dakos are disclosed?

The filing discloses 2,003 SWZ shares held by a limited partnership in which Andrew Dakos has a beneficial interest. He disclaims beneficial ownership of these shares except to the extent of any pecuniary interest, clarifying the nature of his indirect economic exposure.

What is Andrew Dakos’s role at Total Return Securities Fund (SWZ)?

Andrew Dakos is identified as President and CEO and a director of Total Return Securities Fund, ticker SWZ

Were any derivative securities reported in Andrew Dakos’s SWZ Form 4?

No derivative securities are listed with transactions in this Form 4. The Table II section for derivative securities contains headings but no entries, indicating that only non-derivative common stock holdings and purchases were reported in this filing.